Skip to content

AlinityRecalls & reported problems across all models

Abbott Laboratories · 13 models in the FDA device registry

Data updated Oct 16, 2026 from official FDA records · Editorial policy

9 open recalls name at least one Alinity model. Check whether yours is affected in the recall details, and contact the manufacturer or your healthcare provider.

Adverse event reports
2,793
Deaths reported
1
Injuries reported
61
Recalls
10

We found 13 models of Alinity by Abbott Laboratories in the FDA's device registry (GUDID). Together they are named in 2,793 adverse event reports in the FDA's MAUDE database, received between Jan 19, 2018 and Sep 30, 2026 — classified as 1 death, 61 injuries, 2,731 malfunctions.

The most frequently reported specific device problem is “High Test Results” (900 reports).

10 FDA recall records name at least one of these models by its device identifier, 9 still open.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event. Widely used products collect more reports, so totals can't be used to compare products or estimate failure rates. Only reports that name a model's exact device identifier are counted. What reports can and can't tell you · How this data works

Reports received per month, all models

Nov 2023: 34 reportsDec 2023: 37 reportsJan 2024: 45 reportsFeb 2024: 44 reportsMar 2024: 27 reportsApr 2024: 32 reportsMay 2024: 53 reportsJun 2024: 27 reportsJul 2024: 30 reportsAug 2024: 47 reportsSep 2024: 39 reportsOct 2024: 38 reportsNov 2024: 20 reportsDec 2024: 36 reportsJan 2025: 48 reportsFeb 2025: 29 reportsMar 2025: 39 reportsApr 2025: 31 reportsMay 2025: 48 reportsJun 2025: 34 reportsJul 2025: 54 reportsAug 2025: 29 reportsSep 2025: 29 reportsOct 2025: 48 reportsNov 2025: 31 reportsDec 2025: 68 reportsJan 2026: 45 reportsFeb 2026: 40 reportsMar 2026: 48 reportsApr 2026: 45 reportsMay 2026: 24 reportsJun 2026: 9 reportsJul 2026: 6 reportsAug 2026: 9 reportsSep 2026: 23 reportsOct 2026: 0 reports20242025202668
Last 36 months. The most recent month may be incomplete.

Alinity recalls

FDA recall records that name at least one of these models by its device identifier, newest first. Each recall usually covers specific models or lots, so check the details.

  1. Nov 13, 2025Open, Classified

    Abbott Laboratories is recalling their Alinity ci-series System Control Module, a chemistry/immunoassay anayzer, by correction. The reason for the recall is potential performance issues found in the Alinity ci-series System software versions 3.6.1. and lower that could lead to erroneous results for multiple analytes. The issue was identified by Abbott during the internal testing of complaint investigations.

    Z-0961-2026 · Root cause: Software design · Recall details · FDA record ↗

  2. Sep 18, 2025Open, Classified

    Software issue for hq analyzer results in system not visibly applying appropriate flagging to results when saturation is present which may result in incorrect results.

    Z-0489-2026 · Root cause: Software design · Recall details · FDA record ↗

  3. Jun 14, 2024Open, Classified

    1)If Complete Blood Count with differential and reticulocyte(CBC+Diff+Retic) sample is run, then immediately following on same rack CBC+Diff sample is run, then falsely low red blood cell count may occur, generating falsely high Mean Cell Hemoglobin(MCH)/MCHC and falsely low hematocrit results. 2)Cell events may be incorrectly counted as basophil(BASO), resulting in increased BASO and %BASO counts

    Z-2681-2024 · Root cause: Software design · Recall details · FDA record ↗

  4. Oct 19, 2023Open, Classified

    The devices contain a dry natural rubber (latex) subcomponent, which are not labeled as containing dry natural rubber(latex).

    Z-0681-2024 · Root cause: Under Investigation by firm · Recall details · FDA record ↗

  5. Oct 19, 2023Open, Classified

    The devices contain a dry natural rubber (latex) subcomponent, which are not labeled as containing dry natural rubber(latex).

    Z-0680-2024 · Root cause: Under Investigation by firm · Recall details · FDA record ↗

  6. Sep 29, 2023Open, Classified

    A high recovery of Iron assay has been observed at some customer sites. Internal studies confirmed the positive shift of Quality Control and patient samples results, up to 15% for Iron Products (Alinity c Iron Reagent REF. 08P3920) to be used on Abbott Alinity Instrument and to 30% for Iron Products (IRON REF. 6K95-41 and IRON REF. 6K95- 30) to be used on Abbott Architect Instrument. When using the affected lots, there is a potential for delay in reporting patient results due to QC failure, also a potential for falsely elevated results.

    Z-0326-2024 · Root cause: Under Investigation by firm · Recall details · FDA record ↗

  7. May 30, 2023Open, Classified

    There are potential performance issues found in the Alinity ci-series System software versions 3.4.0 and lower, including: 1) SCC Reagent load error during daily maintenance; 2) Sample Laboratory Report error; 3) Customer requests mechanism to prevent user error when creating new lots of value assigned Calibrators; 4) Error in processing tests after CCCintController encountered an error with the assay information downloaded from SCC; 5) The assay editor does not correctly check sample dilution total volume limits; 6) User-Applied Labels not adhering to Reagent Bottles; 7) ICT Module did not expire after warranty was exceeded. These performance issues could lead to erroneous results for multiple analytes.

    Z-0613-2024 · Root cause: Software design · Recall details · FDA record ↗

  8. Nov 24, 2022Open, Classified

    Reaction vessels may contain a potential contaminant that could affect their optical performance.

    Z-0958-2023 · Root cause: Material/Component Contamination · Recall details · FDA record ↗

  9. Feb 3, 2022Open, Classified

    Software error associated with the immunoassay analyzer wash cycle which is using 1 mL of wash buffer instead of the intended 3 mL of wash buffer to wash the exterior of the probe.

    Z-0749-2022 · Root cause: Under Investigation by firm · Recall details · FDA record ↗

  10. Jun 28, 2019Terminated

    Added an additional SmartWash parameter for the Lithium and Alinity c Lithium Reagent Kit, catalogue number 8L25-30 and 08P5320 to prevent the potential for carryover from the ARCHITECT Lactate Dehydrogenase (LDH) reagent (LN 2P56) may result infalsely elevated lithium patient results

    Z-2552-2019 · Root cause: Under Investigation by firm · Recall details · FDA record ↗

Most reported Alinity problems

Device problems

  • High Test Results900
  • Low Test Results713
  • Patient Data Problem350
  • False Positive Result295
  • Incorrect, Inadequate or Imprecise Result or Readings165
  • Leak/Splash91
  • False Negative Result66
  • Smoking60

Patient problems

  • No Clinical Signs, Symptoms or Conditions1,965
  • No Patient Involvement440
  • No Known Impact Or Consequence To Patient295
  • No Consequences Or Impact To Patient33
  • No Code Available15
  • Exposure to Body Fluids9
  • Needle Stick/Puncture7
  • Insufficient Information6

Alinity models

13 models, most reported first. Each model has its own page with its reports, recalls and device details.

Recent Alinity adverse event reports

The 15 most recent reports across all models, in the reporter's own words as published by the FDA.

Other Abbott Laboratories products

All Abbott Laboratories devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page